Difficulty: Medium
Average Score: 90%
Practice
In which of the following conditions, digitalis is most likely to be beneficial?
Correct answer
D
Rationale
In the context of cardiovascular drugs, understanding the appropriate use of digitalis is crucial for managing various heart conditions effectively. The correct answer, option D, "Heart failure from thyrotoxicosis," is where digitalis is most likely to be beneficial.
Digitalis, specifically digoxin, is a cardiac glycoside commonly used in treating heart failure by increasing myocardial contractility and reducing heart rate. In heart failure associated with thyrotoxicosis, there is often an increase in heart rate and a decrease in myocardial contractility due to the hypermetabolic state induced by excess thyroid hormones. In this scenario, digitalis can help improve contractility and control heart rate, thus benefiting the patient.
Analyzing the incorrect options:
A) Heart failure from valvular lesions: Digitalis is not the first-line treatment for heart failure from valvular lesions. Surgical intervention or valve repair/replacement is often necessary in such cases.
B) Furosemide: Furosemide is a loop diuretic used to manage fluid overload in heart failure but does not address the underlying myocardial contractility issues like digitalis.
C) Heart disease with anemia: While anemia can exacerbate heart failure, digitalis is not specifically indicated for heart failure in the presence of anemia. Treatment would focus on correcting the anemia and optimizing heart failure management.
Educational Context:
Understanding the appropriate use of digitalis in heart failure is essential for healthcare professionals managing cardiovascular conditions. It is crucial to recognize the specific scenarios where digitalis can be beneficial, such as in heart failure associated with thyrotoxicosis, to optimize patient care and outcomes. This question highlights the importance of tailoring pharmacological treatments to the underlying pathophysiology of the patient's condition.
Digitalis, specifically digoxin, is a cardiac glycoside commonly used in treating heart failure by increasing myocardial contractility and reducing heart rate. In heart failure associated with thyrotoxicosis, there is often an increase in heart rate and a decrease in myocardial contractility due to the hypermetabolic state induced by excess thyroid hormones. In this scenario, digitalis can help improve contractility and control heart rate, thus benefiting the patient.
Analyzing the incorrect options:
A) Heart failure from valvular lesions: Digitalis is not the first-line treatment for heart failure from valvular lesions. Surgical intervention or valve repair/replacement is often necessary in such cases.
B) Furosemide: Furosemide is a loop diuretic used to manage fluid overload in heart failure but does not address the underlying myocardial contractility issues like digitalis.
C) Heart disease with anemia: While anemia can exacerbate heart failure, digitalis is not specifically indicated for heart failure in the presence of anemia. Treatment would focus on correcting the anemia and optimizing heart failure management.
Educational Context:
Understanding the appropriate use of digitalis in heart failure is essential for healthcare professionals managing cardiovascular conditions. It is crucial to recognize the specific scenarios where digitalis can be beneficial, such as in heart failure associated with thyrotoxicosis, to optimize patient care and outcomes. This question highlights the importance of tailoring pharmacological treatments to the underlying pathophysiology of the patient's condition.